My path is to help steward humanity 2.0, contributing to greater individual and collective well-being by normalizing responsible psychedelic use.
Two companies have been borne of this mission: The Third Wave and Synthesis.
The Third Wave began in 2015, with an intent of changing the cultural conversation around psychedelics. We offer free education, online courses, and peak performance coaching. Our work has been featured in the BBC, Forbes, and Rolling Stone.
Synthesis is a legal psilocybin retreat outside of Amsterdam.
For many clients, attending Synthesis is a profound and meaningful experience, one that leads to better well-being and deeper clarity on purpose and direction.
Outside of my entrepreneurial endeavors, I speak about the intersection of psychedelics, personal transformation, and professional success.
Paul does an excellent job of bridging the gap between psychedelics and leadership transformation. His work with The Third Wave and Synthesis speaks for itself: an inspiring mission grounded in science, knowledge, and personal experience.
Paul’s mission to normalize psychedelic substances through the lens of microdosing speaks to the growing relevance of these emerging technologies. In building The Third Wave, Paul has created an excellent platform for individuals who want to deepen their understanding of the role psychedelics play in optimal well-being.
Filmmaker, Public Speaker
Paul does a great job of deconstructing and synthesizing tricky subject matter—the stuff that would otherwise be out of reach for most. His presentation is stellar and he holds space on stage like a real pro.
American author, journalist, entrepreneur
The Third Wave
In September 2015, I began working on The Third Wave with the vision of creating an accessible and trustworthy resource about psychedelic substances.
Currently, we're building an educational hub, an academy that will provide professional guidance for both novice and enthusiast. Our intent is to serve the network of psychedelic medicine, helping amplify the work and expertise of others in this important field.
Synthesis is a safe, legal, and modern psilocybin truffle retreat in Amsterdam focused on creative breakthroughs, personal growth, and spiritual development. Co-founded by myself and Martijn Schirp, Synthesis provides an opportunity for individuals to experience incredible personal transformation.
There are few things I love more than sharing my understanding of the relationship between microdosing, inner growth, and leadership development. Let's explore how I can bring this energy to your next event:
Microdosing Psychedelics is a comprehensive guide to all the necessary information on the practice of microdosing – including protocols, benefits, drawbacks, and sourcing. Weaving together anecdotal narratives and preliminary research on the use of small amounts of psychedelics, Microdosing Psychedelics is oriented toward anyone interested in microdosing to improve their general well-being, particularly those in leadership and creative positions.
The Third Wave’s Microdosing course offers a deep dive into the fundamentals and advanced practices about microdosing in one easy-to-digest learning experience. Learn how to 'Become Superhuman' with everything from the basics of how to microdose to advanced best practices.
Education and awareness are the key focuses of The Third Wave's psychedelic advocacy bent, says Austin, adding that there's a lot of misinformation out there related to drugs, not to mention safety concerns...
Silicon Valley's LSD Habit is Exploding
Paul Austin's favorite way to open a TED talk is by telling his audience that he took LSD that day. Austin, 27, bills himself as a professional microdosing coach...
Inside America's Premier Psychedelic Conference
Paul Austin, 26, of Grand Rapids, Mich., a so-called social entrepreneur who runs a website called The Third Wave devoted to getting...
Opening the Mind with Psychedelics
Shown to treat depression, anxiety, addiction, post-traumatic stress and more, clinical trials using psychedelic-assisted therapy instead of pharmaceutical treatment by Johns Hopkins and New York University show...